BREATHE ALD: A Shared Decision-Making Intervention for Adults With Advanced Lung Disease

NCT04930666 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2025-04-15

No results posted yet for this study

Summary

This study aims to:

1. Develop the BREATHE-ALD intervention for adults with Advanced Lung Disease, multiple chronic conditions, and palliative care needs and their caregivers using interviews with 10 advanced lung disease (ALD) adults and their caregivers
2. To evaluate the feasibility and acceptability of intervention procedures; and
3. To explore intervention effects on ALD outcomes

Conditions

  • Pulmonary Disease, Chronic Obstructive
  • Lung Diseases, Interstitial

Interventions

OTHER

BRief intervention to Enhance Adherence to Treatment and HEalth advice in Advanced Lung Disease

BREATHE-ALD utilizes the patient's nurse practitioner (NP) to deliver a brief intervention using motivational interviewing and shared decision making, in a one-time 9-minute intervention. The NP will follow a 4-step script tailored to specific ALD self-management discussed during the most recent visit with the patient's pulmonologist. Step 1: Raise the subject (1½ minute). Step 2: Provide feedback (1½ minutes). Step 3: Enhance engagement (3 minutes). Step 4: Shared decision-making (3 minutes).

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    collaborator OTHER
  • National Institute of Nursing Research (NINR)

    collaborator NIH
  • Columbia University

    lead OTHER

Principal Investigators

  • Maureen George, PhD · Columbia University School of Nursing

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-10
Primary Completion
2025-02-06
Completion
2025-02-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04930666 on ClinicalTrials.gov